PT - JOURNAL ARTICLE AU - Taoran Liu AU - Zonglin He AU - Jian Huang AU - Ni Yan AU - Qian Chen AU - Fengqiu Huang AU - Yuejia Zhang AU - Omolola M Akinwunmi AU - Babatunde Akinwunmi AU - Casper J.P Zhang AU - Yibo Wu AU - Wai-Kit Ming TI - The comparison of vaccine hesitancy of COVID-19 vaccination in China and the United States AID - 10.1101/2021.04.29.21256317 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.29.21256317 4099 - http://medrxiv.org/content/early/2021/05/02/2021.04.29.21256317.short 4100 - http://medrxiv.org/content/early/2021/05/02/2021.04.29.21256317.full AB - Objectives To investigate the differences in vaccine hesitancy and preference of the currently available COVID-19 vaccines between two countries, viz. China and the United States (US).Method A cross-national survey was conducted in both China and the US, and discrete choice experiments as well as Likert scales were utilized to assess vaccine preference and the underlying factors contributing to the vaccination acceptance. A propensity score matching (PSM) was performed to enable a direct comparison between the two countries.Results A total of 9,077 (5,375 and 3,702, respectively, from China and the US) respondents have completed the survey. After propensity score matching, over 82.0% respondents from China positively accept the COVID-19 vaccination, while 72.2% respondents form the US positively accept it. Specifically, only 31.9% of Chinese respondents were recommended by a doctor to have COVID-19 vaccination, while more than half of the US respondents were recommended by a doctor (50.2%), local health board (59.4%), or friends and families (64.8%). The discrete choice experiments revealed that respondents from the US attached the greatest importance to the efficacy of COVID-19 vaccines (44.41%), followed by the cost of vaccination (29.57%), whereas those from China held a different viewpoint that the cost of vaccination covers the largest proportion in their trade-off (30.66%), and efficacy ranked as the second most important attribute (26.34%). Also, respondents from China tend to concerned much more about the adverse effect of vaccination (19.68% vs 6.12%) and have lower perceived severity of being infected with COVID-19.Conclusion While the overall acceptance and hesitancy of COVID-19 vaccination in both countries are high, underpinned distinctions between countries are observed. Owing to the differences in COVID-19 incidence rates, cultural backgrounds, and the availability of specific COVID-19 vaccines in two countries, the vaccine rollout strategies should be nation-dependent.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding received in this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has received the ethical approval at Jinan University Medical Ethics Committee, and the approval code is JNUKY-2021-004All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be achieved via emailing to: wkming{at}connect.hku.hk